Skip to main content
Have a personal or library account? Click to login

Volume 18 (2022): Issue 5 (Dec 2022)

Open Access
Journal detailsArticles & issues
Methodist DeBakey Cardiovascular Journal
Previous issue
Next issue

All volumes and issues in this journal

Issue 5
Issue 4
Issue 3
Issue 2
Issue 1

14 articles
Open Access
|Dec 2022
From the Editor-in-Chief
  
Open Access
|Dec 2022
Cardiovascular Pharmacology: Contemporary Physiologic and Scientific Approaches to Cardiovascular Disease Prevention and Treatment
 and    
Open Access
|Dec 2022
Pharmacotherapy for Essential Hypertension: A Brief Review
,   and    
Open Access
|Dec 2022
Medical Therapy for Heart Failure with Preserved Ejection Fraction
,   and    
Open Access
|Dec 2022
Opportunities for Earlier Diagnosis and Treatment of Cardiac Amyloidosis
,  ,   and    
Open Access
|Dec 2022
Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure
,  ,   and    
Open Access
|Dec 2022
How a New Understanding of Drug or Drug Class Pharmacology Often Drives Drug Development: A Conversation with Steven E. Nissen, MD
 and    
Open Access
|Dec 2022
The Future of Antiarrhythmic Drug Therapy: Will Drugs Be Entirely Replaced by Procedures?
  
Open Access
|Dec 2022
Future Impact of mRNA Therapy on Cardiovascular Diseases
 and    
Open Access
|Dec 2022
Constantly Bombarded with New Drugs: What’s a Cardiologist to Do?
 and    
eISSN: 1947-6108|Language: English
Website: https://journal.houstonmethodist.org
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Journal RSS Feed